Pugazhenthan Thangaraju

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Venues

Infectious disorders drug targets

Revista da Sociedade Brasileira de Medicina Tropical

SN comprehensive clinical medicine

Dermatologic therapy

All India Institute of Medical Sciences - Raipur

This page only lists publications with an associated author ORCID identifier.

Affiliation History

All India Institute of Medical Sciences - Raipur Oct 16 2018

India

ASSISTANT PROFESSOR :: PHARMACOLOGY

Central Leprosy Training and Research Institute Aug 26 2013 - Oct 15 2018

India

MEDICAL OFFICER :: CLINICAL DIVISION

Publications

Hemasri Velmurugan, Sajitha Venkatesan, Hadush Negash Meles, Krishnapriya Neelambaram, Pugazhenthan Thangaraju
Sulbactam-Durlobactam, A Novel Drug for the Treatment of Multidrug Resistant Acinetobacter baumannii Infections - A Systematic Review. Infectious disorders drug targets 24 (6) (2024)
Sadasivam Nehru, Pugazhenthan Thangaraju, Nehru Cibee, Hemasri Velmurugan
Dog Bite Injury: Rusk Became a Risk - A Case Report. Infectious disorders drug targets (2024)
Hemasri Velmurugan, Sajitha Venkatesan, Hadush Negash Meles, Pugazhenthan Thangaraju, Krishnapriya Neelambaram
Sulbactam-Durlobactam, A Novel Drug for the Treatment of Multidrug-resistant Acinetobacter baumannii Infections - A Systematic Review. Infectious disorders drug targets (2024)
Raja Narendra Divakar Addanki, Anjali Srikanth Mannava, Hemasri Velmurugan, Pugazhenthan Thangaraju
Treatment Modalities for Trigeminal Neuralgia and the Need for Vigilance in Monitoring Adverse Drug Events: A Case Report. Current drug safety (2024)
Pugazhenthan Thangaraju, Sajitha Venkatesan
Vigilance Needed in Polypharmacy Drugs. WMJ : official publication of the State Medical Society of Wisconsin 123 (3) (2024)
Pugazhenthan Thangaraju, Sajitha Venkatesan
Vigilance Needed in Polypharmacy Drugs. WMJ : official publication of the State Medical Society of Wisconsin 123 (3) (2024)
Sadasivam Nehru, Pugazhenthan Thangaraju, Nehru Cibee, Hemasri Velmurugan
Dog Bite Injury: Rusk Became a Risk - A Case Report. Infectious disorders drug targets 24 (6) (2024)
Hemasri Velmurugan, Anjali Srikanth Mannava, Pugazhenthan Thangaraju, Krishnapriya Neelambaran
Kisspeptin and its Current Clinical Status- A Systematic Review. Current medicinal chemistry (2024)
Hemasri Velmurugan, Sajitha Venkatesan, Hadush Negash Meles, Krishnapriya Neelambaram, Pugazhenthan Thangaraju
Sulbactam-Durlobactam, A Novel Drug for the Treatment of Multidrug Resistant Acinetobacter baumannii Infections - A Systematic Review. Infectious disorders drug targets 24 (6) (2024)
Hemasri Velmurugan, Krishnapriya Neelambaran, Meenalotchini Prakash Gurunthalingam, Dushyant Chouhan, Pugazhenthan Thangaraju, Bikram Keshari Kar, Nitin Rewaram Gaikwad
Vigilance Needed in Treating a Child with Disseminated TB: A Case Report. Infectious disorders drug targets (2024)
Raja Narendra Divakar Addanki, Anjali Srikanth Mannava, Hemasri Velmurugan, Pugazhenthan Thangaraju
Treatment Modalities for Trigeminal Neuralgia and the Need for Vigilance in Monitoring Adverse Drug Events: A Case Report. Current drug safety 19 (4) (2024)
Pugazhenthan Thangaraju, Himanshu Nirmal Chandu, Hemasri Velmurugan, Pankaj Kumar Kannauje, R Arun Kumar
Analysis of Research Publications on Pharmacogenomics of Sulphonylurea - A Scientometric Study. Current diabetes reviews (2023)
Hemasri Velmurugan, Pugazhenthan Thangaraju
Nutritional Status in Leprosy Patients: A Systematic Review and Metaanalysis. Infectious disorders drug targets (2023)
Ripu Daman Arora, Pugazhenthan Thangaraju
Pott's puffy tumor in coronavirus disease-2019 associated mucormycosis. Revista da Sociedade Brasileira de Medicina Tropical 55 (2022)
Surjit Singh, Saurabh Singh, Abisha Thangaswamy, Pugazhenthan Thangaraju, Shobhan Babu Varthya
Efficacy and safety of Risankizumab in moderate to severe psoriasis: A systematic review and meta-analysis. Dermatologic therapy 34 (1) (2020)
Pugazhenthan Thangaraju, Sajitha Venkatesan, Meenalotchini Gurunthalingam, Shoban Babu, Tamilselvan T
Rationale use of Thalidomide in erythema nodosum leprosum - A non-systematic critical analysis of published case reports. Revista da Sociedade Brasileira de Medicina Tropical 53 (2020)
Pugazhenthan Thangaraju, Sajitha Venkatesan
Leprosy reactions: Earlier diagnosis leads to more effective treatment. Revista da Sociedade Brasileira de Medicina Tropical 53 (2020)
Pugazhenthan Thangaraju, Nanditha Venkatesan, T Y Sree Sudha, Sajitha Venkatesan, Eswaran Thangaraju
Role of Dupilumab in Approved Indications of COVID-19 Patient: an Efficacy-Based Nonsystematic Critical Analysis. SN comprehensive clinical medicine (2020)
Yegnaraman Venkatakrishnan, Pugazhenthan Thangaraju, Sathya Jeganathan, Suresh K Sankaran, Rajkumar Kannan
Nutritional status and morbidity profile of children with leprosy contact in a rural community. Tropical doctor 50 (4) (2020)
Pugazhenthan Thangaraju, Nanditha Venkatesan, Eswaran Thangaraju, Sajitha Venkatesan
Are We Jumping the Gun with Itolizumab in India? A Situational Analysis from the Pre-COVID Era. SN comprehensive clinical medicine (2020)
Pugazhenthan Thangaraju, Nanditha Venkatesan, Sajitha Venkatesan, Meenalotchini Prakash Gurunthalingam, Eswaran Thangaraju
Can HCQ Be Considered a "Safe Weapon" for COVID-19 in the Indian Population? SN comprehensive clinical medicine (2020)
Sajitha Venkatesan, Pugazhenthan Thangaraju
De novo histoid leprosy - Further points of focus. Revista da Sociedade Brasileira de Medicina Tropical 52 (2019)
Sajitha Venkatesan, Pugazhenthan Thangaraju
Rationale in diagnosis and management: role of screening and history taking. Tropical doctor 49 (3) (2019)
Pugazhenthan Thangaraju, Sajitha Venkatesan, Showkath Ali Mk
Minocycline: A strategy for unresponsive nerve function impairment. Dermatologic therapy 30 (6) (2017)

Pugazhenthan Thangaraju.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pugazhenthan Thangaraju